Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BP-IL17RB: IL-17B/IL-17RB Axis in Bullous Pemphigoid
NCT06479018Recruiting
- Sponsor
- CHU de Reims
- Start
- Feb 2022
- Primary completion
- Jan 2025
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by CHU de Reims. Primary endpoints: Identification of IL-17RB-expressing cells and IL-17B-producing cells in blood at Day 365 and Identification of IL-17RB-expressing cells at the lesional site at Day 60. Started Feb 2022; status: recruiting.
Beyond the preview
Go deeper on NCT06479018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06479018.